Research Article
Safety and Efficacy of Second-Generation Drug-Eluting Stents in Real-World Practice: Insights from the Multicenter Grand-DES Registry
Table 4
Independent predictors of stent thrombosis in crude population group.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
∗Identification of independent predictors was done with Cox proportional hazard regression model, and the variables were presented with multivariable-adjusted HRs, 95% CI, and -values. †Variables included in the model are old age, diabetes mellitus, chronic renal failure, previous PCI, previous CABG, left ventricular dysfunction, premature SAPT, STEMI, multiple lesion, American College of Cardiology/American Heart Association B2/C lesions, previous treated lesion, total stent length, and major classification of used stent. ‡Variables included in the model are old age, diabetes mellitus, chronic renal failure, previous MI, left ventricular dysfunction, STEMI, multiple lesion, American College of Cardiology/American Heart Association B2/C lesions, total stent length, small diameter, and major classification of used stent. §Variables included in the model are old age, chronic renal failure, previous MI, previous PCI, left ventricular dysfunction, STEMI, premature SAPT, American College of Cardiology/American Heart Association B2/C lesions, previous treated lesion, long lesion, small diameter, and major classification of used stent. HR = hazard ratio; CI = confidence interval; PCI = percutaneous coronary intervention; SAPT = single antiplatelet agent therapy; STEMI = ST-segment elevation myocardial infarction; MI = myocardial infarction; CABG = coronary artery bypass surgery. |